AMREEN DINANI

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology NEW YORK, NY NPI 1386808525

General Payments — all program years on this page

$82,687.02

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 116
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $43,596.53 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $35,129.7412
Madrigal Pharmaceuticals $8,319.604
Gilead Sciences, Inc. $122.241
INTERCEPT PHARMACEUTICALS, INC. $24.951

By program year

Program yearAmountRecords
2018 $2,002.3126
2019 $15,188.4139
2020 $8,600.0614
2021 $6,701.0911
2022 $297.744
2023 $6,300.884
2024 $43,596.5318

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096618110 Novo Nordisk Inc $224.39 04/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096988607 Novo Nordisk Inc $3,100.00 11/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1097401371 Novo Nordisk Inc $2,712.50 09/27/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1097492738 Novo Nordisk Inc $199.95 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097494245 Novo Nordisk Inc $665.79 04/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097497662 Novo Nordisk Inc $876.82 09/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097499142 Novo Nordisk Inc $3,100.00 01/03/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1097655638 Novo Nordisk Inc $11,043.75 04/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1097671765 Novo Nordisk Inc $1,153.25 04/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1097693600 Novo Nordisk Inc $10,656.25 09/20/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1097838557 Novo Nordisk Inc $900.93 04/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097838700 Novo Nordisk Inc $496.11 09/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1113630420 Intercept Pharmaceuticals, Inc. $24.95 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133778001 Gilead Sciences, Inc. $122.24 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144164679 Madrigal Pharmaceuticals $3,350.00 10/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1144164681 Madrigal Pharmaceuticals $3,878.00 11/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1144164683 Madrigal Pharmaceuticals $123.10 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144164685 Madrigal Pharmaceuticals $968.50 11/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.